2008
DOI: 10.1016/j.vaccine.2008.07.061
|View full text |Cite
|
Sign up to set email alerts
|

The GAVI Financing Task Force: One model of partner collaboration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…In light of its support to countries, Gavi has prioritized nancial sustainability especially at country level despite the challenges and limitations in its approaches (29). This has been through its policies on eligibility, transition and nancing to enable countries fully nance immunization programs beyond the time limited contribution from Gavi (27,29,44,45). Also, National Immunization Technical Advisory Groups have been established as independent technical bodies to guide immunization programs and ensure evidenced based decision making especially on new vaccine introduction (13,46).…”
Section: Discussionmentioning
confidence: 99%
“…In light of its support to countries, Gavi has prioritized nancial sustainability especially at country level despite the challenges and limitations in its approaches (29). This has been through its policies on eligibility, transition and nancing to enable countries fully nance immunization programs beyond the time limited contribution from Gavi (27,29,44,45). Also, National Immunization Technical Advisory Groups have been established as independent technical bodies to guide immunization programs and ensure evidenced based decision making especially on new vaccine introduction (13,46).…”
Section: Discussionmentioning
confidence: 99%
“…3 The introduction of human papillomavirus (HPV) vaccines is one challenge currently facing developing countries. Globally, there may be more than a decade-long time lag between introduction of a new vaccine in industrialized countries and introduction in low-resource countries.…”
Section: Preventing Vaccine-preventable Diseases In Low-resource Commmentioning
confidence: 99%